SCHEMBL31728091

SCHEMBL31728091

Nc1ncnc2c(-c3ccn4nccc4c3F)cccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 4/20 0.36
▸ LIMK1 P53667 6/20 0.35
▸ PI4KA P42356 3/20 0.33
▸ PI4K2B Q8TCG2 3/20 0.33
▸ PI4K2A Q9BTU6 3/20 0.33
▸ PI4KB Q9UBF8 3/20 0.33
▸ CDC7 O00311 1/20 0.32
▸ CLK1 P49759 1/20 0.32
▸ DBF4 Q9UBU7 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ CYP17A1 P05093 2/20 0.31
▸ CDK5 Q00535 1/20 0.31
▸ CDK5R1 Q15078 1/20 0.31
▸ RIPK2 O43353 1/20 0.31
▸ PRKD3 O94806 1/20 0.31
▸ ABL1 P00519 1/20 0.31
▸ FYN P06241 1/20 0.31
▸ SRC P12931 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ CSK P41240 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728557 0.69 RPS6KA1 (0.31) —
SCHEMBL29728040 0.66 PI4KA (0.48) MAP4K4LIMK1PI4KAPI4K2BPI4K2A
SCHEMBL31291221 0.66 MAP4K4 (0.36) MAP4K4
SCHEMBL20399046 0.66 PI4KA (0.48) MAP4K4LIMK1PI4KAPI4K2BPI4K2A
SCHEMBL31291220 0.66 MAP4K4 (0.36) MAP4K4
SCHEMBL30639393 0.66 LIMK1 (0.49) MAP4K4LIMK1PI4KAPI4K2BPI4K2A
SCHEMBL30639391 0.66 LIMK1 (0.63) MAP4K4LIMK1PI4KAPI4K2BPI4K2A
SCHEMBL30639390 0.65 PI4KA (0.49) LIMK1PI4KAPI4K2BPI4K2API4KB
SCHEMBL245963 0.65 MAP4K4 (0.43) MAP4K4LIMK1CDC7CLK1DBF4
SCHEMBL30639400 0.64 LIMK1 (0.46) MAP4K4LIMK1PI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback